An "ATRA-ctive" new treatment of ITP?
BLOOD（2022）
Abstract
In this issue of Blood, Wu and colleagues(1) present encouraging results from one of the accumulating studies evaluating use of all-trans retinoic acid (ATRA) in adult patients with immune thrombocytopenia (ITP).
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined